Generate a tailored SOP for Dr. Richard Treisman. Improve your application with a focused, well-structured draft.
Richard Treisman is the Director of Research at the Francis Crick Institute, an organization he helped establish in 2015. He previously played a significant role at the Cancer Research UK London Research Institute, formerly known as the Imperial Cancer Research Fund, where he served from 2000 to 2015. Treisman's research primarily focuses on the regulation of transcription and cell signaling, particularly through the study of the serum response factor (SRF) and its regulatory cofactors. He has been recognized for his contributions to the field, being a member of the European Molecular Biology Organization and a Fellow of the Royal Society. His research has led to insights regarding the molecular mechanisms by which extracellular signals can influence gene expression. Treisman has received several prestigious awards, including the EMBO Medal in 1995 and the Louis-Jeantet Prize in Medicine in 2002. He obtained his PhD from the Imperial Cancer Research Fund in 1981 and completed postdoctoral research at Harvard University, before joining the Medical Research Council Laboratory of Molecular Biology in Cambridge.
Francis Crick Institute • London, England
Responsible for leading research initiatives and overseeing scientific projects at the institute.
Cancer Research UK London Research Institute • London, England
Oversaw cancer research programs and laboratories.
MRC Laboratory of Molecular Biology • Cambridge, England
Engaged in research focused on transcription and gene regulation.
The Francis Crick Institute does not have traditional 'departments' but operates via interdisciplinary research groups. Candidates apply to the 'Crick PhD Programme' and select specific research topics or labs (e.g., Cell Biology, Immunology, Cancer Research) that align with the listed department names. Students register with one of three partner universities: UCL, King's College London, or Imperial College London.